The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Protective effect of green tea against prostate cancer: A case‐control study in southeast China
Open accessAbstract
To investigate whether green tea consumption has an etiological association with prostate cancer, a case‐control study was conducted in Hangzhou, southeast China during 2001–2002. The cases were 130 incident patients with histologically confirmed adenocarcinoma of the prostate. The controls were 274 hospital inpatients without prostate cancer or any other malignant diseases, and matched to the age of cases. Information on duration, quantity and frequency of usual tea consumption, as well as the number of new batches brewed per day, were collected by face‐to‐face interview using a structured questionnaire. The risk of prostate cancer for tea consumption was assessed using multivariate logistic regression adjusting for age, locality, education, income, body mass index, physical activity, alcohol consumption, tobacco smoking, total fat intake, marital status, age at marriage, number of children, history of vasectomy and family history of prostate cancer. Among the cases, 55.4% were tea drinkers compared to 79.9% for the controls. Almost all the tea consumed was green tea. The prostate cancer risk declined with increasing frequency, duration and quantity of green tea consumption. The adjusted odds ratio (OR), relative to non‐tea drinkers, were 0.28 (95% CI = 0.17–0.47) for tea drinking, 0.12 (95% CI = 0.06–0.26) for drinking tea over 40 years, 0.09 (95% CI = 0.04–0.21) for those consuming more than 1.5 kg of tea leaves yearly, and 0.27 (95% CI = 0.15–0.48) for those drinking more than 3 cups (1 litre) daily. The dose response relationships were also significant, suggesting that green tea is protective against prostate cancer. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compendium of physical activities: an update of activity codes and MET intensities
AINSWORTH, B. E., HASKELL, W. L., WHITT, M. C., IRWIN, M. L., SWARTZ, A. M., STRATH, S. J., O???BRIEN, W. L., BASSETT, D. R., SCHMITZ, K. H., EMPLAINCOURT, P. O., et al. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009001-00009 · Cited by 8,497
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Dietary Assessment Resource Manual
Thompson, F. E., & Byers, T. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.suppl_11.2245s · Cited by 1,240
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.334 · Cited by 950
International trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.652 · Cited by 665
Adlercreutz, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00777-5 · Cited by 661
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., & Mukhtar, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171326098 · Cited by 486
Striegel, S. (1988) · Journal of Nutrition Education · doi:10.1016/s0022-3182(88)80163-8 · Cited by 241
Cited by
Beneficial Effects of Green Tea—A Review
Cabrera, C., Artacho, R., & Giménez, R. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719518 · Cited by 1,904
Tea Polyphenols for Health Promotion
Khan, N., & Mukhtar, H. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.011 · Cited by 1,156
Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., & Corti, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1145 · Cited by 815
Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4414 · Cited by 732
A Review of the Health Effects of Green Tea Catechins in In Vivo Animal Models
Crespy, V., & Williamson, G. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.12.3431s · Cited by 598
Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
Khan, N., Afaq, F., & Mukhtar, H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1740 · Cited by 591
Perspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Targeting antioxidants for cancer therapy
Glasauer, A., & Chandel, N. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.017 · Cited by 499
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Role of Diet in Prostate Cancer Development and Progression
Chan, J. M., Gann, P. H., & Giovannucci, E. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1492 · Cited by 413
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505870102 · Cited by 401
Multitargeted therapy of cancer by green tea polyphenols
Khan, N., & Mukhtar, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.014 · Cited by 363
Ferraz, C. R., Carvalho, T. T., Manchope, M. F., Artero, N. A., Rasquel-Oliveira, F. S., Fattori, V., Casagrande, R., & Verri, W. A. (2020) · Molecules · doi:10.3390/molecules25030762 · Cited by 349
Green tea (Camellia sinensis) for the prevention of cancer
Filippini, T., Malavolti, M., Borrelli, F., Izzo, A. A., Fairweather-Tait, S. J., Horneber, M., & Vinceti, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005004.pub3 · Cited by 327
Natural and synthetic antioxidants: An updated overview
Augustyniak, A., Bartosz, G., Čipak, A., Duburs, G., Horáková, L., Łuczaj, W., Majekova, M., Odysseos, A. D., Rackova, L., Skrzydlewska, E., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.508495 · Cited by 319
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., & Mukhtar, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2840 · Cited by 296
Green Tea Consumption and Prostate Cancer Risk in Japanese Men: A Prospective Study
Kurahashi, N., Sasazuki, S., Iwasaki, M., Inoue, M., & Shoichiro Tsugane for the JPHC Study Group (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm249 · Cited by 282
Chen, Q., Zhao, J., Fang, C. H., & Wang, D. (2007) · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2006.03.038 · Cited by 263
Clinical development of novel proteasome inhibitors for cancer treatment
Yang, H., Zonder, J. A., & Dou, Q. P. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903002074 · Cited by 85
Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
Zhang, L., He, Y., Wu, X., Zhao, G., Zhang, K., Yang, C. S., Reiter, R. J., & Zhang, J. (2019) · Cells · doi:10.3390/cells8070745 · Cited by 30
Weinstein, B. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_1 · Cited by 17
Metadata
- Authors
- Jian, L., Xie, L. P., Lee, A. H., & Binns, C. W.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-10-07
- Volume
- 108
- Issue
- 1
- Pages
- 130-135
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2016313181
- Cited by
- 369
- References
- 25
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.